During the past decade, Chu Nimes conducted 572 clinical trials. In the 10-year time frame, 572 clinical trials started and 30 clinical trials were completed, i.e. on average, 5.2% percent of trials that started reached the finish line to date. In the past 5 years, 312 clinical trials started and 24 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chu Nimes" #1 sponsor was "Centre Hospitalier Universitaire de Nīmes" with 380 trials, followed by "University Hospital, Montpellier" with 25 trials sponsored, "University Hospital, Clermont-Ferrand" with 12 trials sponsored, "Groupe Francophone des Myelodysplasies" with 11 trials sponsored and "University Hospital, Toulouse" with 11 trials sponsored. Other sponsors include 318 different institutions and companies that sponsored additional 141 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chu Nimes" #1 collaborator was "Centre Hospitalier Universitaire de Nīmes" with 9 trials as a collaborator, "Ministry of Health, France" with 9 trials as a collaborator, "Bayer" with 5 trials as a collaborator, "Centre Hospitalier Universitaire Dijon" with 5 trials as a collaborator and "Hospices Civils de Lyon" with 5 trials as a collaborator. Other collaborators include 337 different institutions and companies that were collaborators in the rest 286 trials.

According to Clinical.Site data, the most researched conditions in "Chu Nimes" are "Multiple Sclerosis" (20 trials), "Stroke" (11 trials), "Prostate Cancer" (10 trials), "Colorectal Cancer" (9 trials) and "Acute Myeloid Leukemia" (8 trials). Many other conditions were trialed in "Chu Nimes" in a lesser frequency.

Most popular intervention types in "Chu Nimes" are "Other" (239 trials), "Drug" (221 trials), "Procedure" (114 trials), "Device" (92 trials) and "Biological" (48 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (51 trials), "Blood test" (11 trials), "placebo" (7 trials), "Lenalidomide" (6 trials) and "Rituximab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Chu Nimes" are 653 trials for "All" genders, 89 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are 253 active trials in "Chu Nimes". 15 are not yet recruiting, 185 are recruiting, 51 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 407 completed trials in Chu Nimes, undefined suspended trials, and 57 terminated clinical trials to date.

Out of the total trials that were conducted in Chu Nimes, 7 "Phase 1" clinical trials were conducted, 70 "Phase 2" clinical trials and 118 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 231 trials that are defined as “Not Applicable".

Chu Nimes has several departments that took part in Clinical trials: "Institut de cancerologie du Gard" - 17 trials, "CHU de Nîmes Hopital Caremeau; Service de Neurologie" - 9 trials, "Hopital Caremeau; Gastro Enterologie" - 4 trials, "Hopital Caremeau; Hematologie Oncologie" - 4 trials, "Hopital Caremeau; Pneumologie" - 3 trials, "Hopital Caremeau, Service de Psychiatrie A" - 3 trials, "Centre Hospitalier Uni Ire Caremeau; Radiotherapie & Oncologie" - 2 trials, "Service de cardiologie, CHU Nîmes" - 2 trials, "CHU NIMES - Unité de Sommeil" - 2 trials, "Virologie" - 2 trials